ArticlePloS one2025
Genetic etiology and pregnancy outcomes of abnormal fluid accumulation in fetus: A retrospective cohort study.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThis study investigated the genetic etiology of abnormal fetal fluid accumulation, aiming to quantify pathogenic variants and correlate them with clinical outcomes to improve genetic counseling.
methodsA cohort of 305 fetuses underwent single-nucleotide polymorphism array (SNP-array) and whole-exome sequencing (WES) of amniotic fluid or cord blood.
resultsPathogenic copy number variations (CNVs) were detected in 49 cases, including aneuploidies (e.g., trisomy 21, Turner syndrome) and microdeletions/duplications. Two single-gene mutations (SNAP25, PLD1) were identified in CNV-negative cases. Non-immune hydrops (NIHF) exhibited the highest pathogenic rate (42.7%, 32/75), with non-isolated NIHF (50.0%) showing significantly higher detection than isolated NIHF (17.6%). NIHF also had the highest termination rate and postnatal abnormality rate (11%). Pleural and pericardial effusions followed in severity.
interpretationThe findings demonstrate that SNP-array and WES effectively diagnose genetic causes of fluid accumulation. While some NIHF cases may have favorable outcomes, the high termination and abnormality rates underscore its generally poor prognosis. These results emphasize the importance of comprehensive prenatal genetic testing and individualized counseling for families facing such diagnoses.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.